Tissue CEA as a prognostic factor in patients with breast cancer
Haase, W.
Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft . 171(2): 117-118
1995
ISSN/ISBN: 0179-7158 PMID: 7863426 Document Number: 449110
Document emailed within 1 workday
Related Documents
Sheen-Chen, S.-M.; Chou, F.-F.; Hsu, W.; Huang, C.-C.; Eng, H.-L.; Tang, R.-P. 2007: Lack of prognostic value of insulin-like growth factor-1 in patients with breast cancer: analysis with tissue microarray Anticancer Research 27(5b): 3541-3544Eskelinen, M.; Lipponen, P.; Syrjänen, K. 1991: TAG 12 expression as a prognostic factor in female breast cancer Anticancer Research 11(5): 1683-1686
Utada, Y.; Emi, M.; Haga, S.; Kajiwara, T. 2000: Allelic loss as prognostic factor in breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 473-477
Yamashita, J.; Ogawa, M.; Beppu, T. 1993: Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer cell lines Research Communications in Chemical Pathology and Pharmacology 82(2): 249-252
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. I. Prognostic factors in patients with node-negative (N0) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 159-163
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 165-170
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Foekens, J.A.; Portengen, H.; van Putten, W.L.; Trapman, A.M.; Reubi, J.C.; Alexieva-Figusch, J.; Klijn, J.G. 1989: Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer Cancer Research 49(24 Part 1): 7002-7009
Jansen, R.L.; Joosten-Achjanie, S.R.; Volovics, A.; Arends, J.W.; Hupperets, P.S.; Hillen, H.F.; Schouten, H.C. 1998: Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer Anticancer Research 18(6a): 4455-4462
Wang, S.-l.; Li, Y.-x.; Song, Y.-w.; Wang, W.-h.; Jin, J.; Liu, Y.-p.; Liu, X.-f.; Yu, Z.-h. 2010: Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy Zhonghua Zhong Liu Za Zhi 32(7): 520-525
Jansen, R.L.; Hupperets, P.S.; Arends, J.W.; Joosten-Achjanie, S.R.; Volovics, A.; Hillen, H.F.; Schouten, H.C. 1998: pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer Anticancer Research 18(1b): 577-582
Bonneterre, J.; Peyrat, J.P.; Beuscart, R.; Demaille, A. 1990: Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer Cancer Research 50(21): 6931-6935
Schultz, D.C.; Bazel, S.; Wright, L.M.; Tucker, S.; Lange, M.K.; Tachovsky, T.; Longo, S.; Niedbala, S.; Alhadeff, J.A. 1994: Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls Cancer Research 54(1): 48-54
Beer, A.E.; Billingham, R.E. 1978: Adipose tissue, a neglected factor in aetiology of breast cancer? Lancet 2(8084): 296
Rajeswari, S.; Ghosh, S.N.; Shah, P.N.; Borah, V.J. 1977: Barr body frequency in the human breast cancer tissue. A prospective study on its prognostic value and its correlation with specific oestradiol receptors European Journal of Cancer 13(2): 99-102
Zhu, Z.R.; Parviainen, M.; Männistö, S.; Pietinen, P.; Eskelinen, M.; Syrjänen, K.; Uusitupa, M. 1995: Vitamin a concentration in breast adipose tissue of breast cancer patients Anticancer Research 15(4): 1593-1596
Kaido, T.; Oe, H.; Yoshikawa, A.; Mori, A.; Arii, S.; Imamura, M. 2005: Tissue factor is a useful prognostic factor of recurrence in hepatocellular carcinoma in 5-year survivors Hepato-Gastroenterology 52(65): 1383-1387
Molina, R.; Segui, M.A.; Climent, M.A.; Bellmunt, J.; Albanelll, J.; Fernandez, M.; Filella, X.; Jo, J.; Gimenez, N.; Iglesias, E.; Miralles, M.; Alonso, C.; Peiro, G.; Perez-Picañol, E.; Ballesta, A.M. 1998: p53 oncoprotein as a prognostic indicator in patients with breast cancer Anticancer Research 18(1b): 507-511
Bianchi, A.; Mallofre, C.; Serrano, A.; Suñol, J.; Barja, J.; Ubach, M. 1993: DNA as a prognostic factor in colorectal cancer. A retrospective analysis of 34 patients Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 84(2): 100-104
Almus, F.E.; Rao, L.V.; Rapaport, S.I. 1989: Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells Thrombosis and Haemostasis 62(4): 1067-1073